NASDAQ · Medical - Distribution

HSIC (HSIC) Stock

$86.51 +0.89% NASDAQ: HSIC Healthcare

Valuation

MetricValue
Price$86.51
Market Cap$9.85B
P/E Ratio22.31
P/B Ratio2.56
P/S Ratio0.62
EPS (TTM)$3.27
52-Week High$89.29
52-Week Low$61.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE12.27%
ROA3.55%
ROCE15.81%
Gross Margin5.75%
Operating Margin5.75%
Net Margin2.95%
Debt/Equity1.15
Current Ratio1.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$12.4B$12.6B$12.3B$12.7B$13.2B
Operating Profit$855.0M$938.0M$714.0M$729.0M$758.0M
Net Profit$624.0M$538.0M$416.0M$390.0M$398.0M
EPS$4.45$3.91$3.16$3.05$3.27
Op Margin6.9%7.4%5.8%5.8%5.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$8.5B$8.6B$10.6B$10.2B$11.2B
Total Liabilities$3.8B$3.9B$5.4B$5.4B$6.4B
Cash$118.0M$117.0M$171.0M$122.0M$156.0M
Borrowings$1.2B$1.5B$2.7B$2.9B$3.7B

Latest News

Henry Schein (HSIC) Could Be 3% Undervalued As Earnings Come Into Focus Simply Wall St. · Jul 22, 2026 HSIC: Lowering target price to $90.00 Argus Research · Jul 22, 2026 Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET Business Wire · Jul 21, 2026 Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report? Zacks · Jul 20, 2026 Leerink Partners Adjusts Price Target on Henry Schein to $88 From $83, Maintains Market Perform Rating MT Newswires · Jul 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$710.0M$602.0M$500.0M$848.0M$712.0M
Investing Cash Flow$-756.0M$-372.0M$-1.3B$-617.0M$-616.0M
Financing Cash Flow$-490.0M$-542.0M$-199.0M$-699.0M$-914.0M
Net Cash Flow$-303.0M$-1.0M$54.0M$-49.0M$34.0M
Free Cash Flow$631.0M$506.0M$353.0M$661.0M$573.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA11.08
FCF Yield5.19%
Quick Ratio0.75
Interest Coverage5.05
Return 1Y24.31%
Return 3Y7.43%
Return 5Y12.32%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATR $136.77 +2.10% 19.32 $8.73B 1.66%
AVTR $13.36 -2.34% -9.79 $9.04B 0.00%
BIO $330.54 +4.47% 10.29 $8.94B 0.00%
DVADaVita Inc. $236.58 +0.48% 23.20 $15.18B 0.00%
GMED $80.19 +2.48% 20.18 $10.81B 0.00%

About HSIC

HSIC is led by CEO Frederick Lowery, employs 25,000 people, headquartered in Melville, US, publicly traded since 1995.

HSIC stock trades at $86.51 with a market capitalization of $9.85B. The stock is valued at a price-to-earnings (P/E) ratio of 22.31, price-to-book of 2.56, price-to-sales of 0.62. Over the past 52 weeks the stock has ranged between $61.95 and $89.29, and currently trades 3.1% below its 52-week high.

On profitability, HSIC generates a return on equity (ROE) of 12.27%, above the typical market average, return on capital employed of 15.81%, an operating margin of 5.75%, a net profit margin of 2.95%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides